Literature DB >> 20309846

Increased risk of high-grade prostate cancer among infertile men.

Thomas J Walsh1, Michael Schembri, Paul J Turek, June M Chan, Peter R Carroll, James F Smith, Michael L Eisenberg, Stephen K Van Den Eeden, Mary S Croughan.   

Abstract

BACKGROUND: It has been reported that fatherhood status may be a risk factor for prostate cancer. In the current study, the authors examined the subsequent occurrence of prostate cancer in a cohort of men evaluated for infertility to determine whether male infertility is a risk factor for prostate cancer.
METHODS: A total of 22,562 men who were evaluated for infertility from 1967 to 1998 were identified from 15 California infertility centers and linked to the California Cancer Registry. The incidence of prostate cancer was compared with the incidence in an age-matched and geography-matched sample of men from the general population. The risk of prostate cancer in men with and those without male factor infertility was modeled using a Cox proportional hazards regression model.
RESULTS: A total of 168 cases of prostate cancer that developed after infertility were identified. Men evaluated for infertility but not necessarily with male factors were not found to have an increased risk of cancer compared with the general population (standardized incidence ratio [SIR], 0.9; 95% confidence interval [95% CI], 0.8-1.1). This risk was found to be highest for men with male factor infertility who developed high-grade prostate cancer (SIR, 2.0; 95% CI, 1.2-3.0). On multivariate analyses, men with male factor infertility were found to be 2.6 times more likely to be diagnosed with high-grade prostate cancer (hazard ratio, 2.6; 95% CI, 1.4-4.8).
CONCLUSIONS: Men with male factor infertility were found to have an increased risk of subsequently developing high-grade prostate cancer. Male infertility may be an early and identifiable risk factor for the development of clinically significant prostate cancer. (c) 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20309846      PMCID: PMC2893877          DOI: 10.1002/cncr.25075

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Incidence of prostatic carcinoma in the elderly.

Authors:  I Rullis; J A Shaeffer; O M Lilien
Journal:  Urology       Date:  1975-09       Impact factor: 2.649

2.  Increased frequency of mutations in DNA from infertile men with meiotic arrest.

Authors:  D Nudell; M Castillo; P J Turek; R R Pera
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

3.  Meta-analysis of measures of sexual activity and prostate cancer.

Authors:  Leslie K Dennis; Deborah V Dawson
Journal:  Epidemiology       Date:  2002-01       Impact factor: 4.822

4.  Cancer of the prostate in men less than 50 years old: an analysis of 51 cases.

Authors:  D P Byar; F K Mostofi
Journal:  J Urol       Date:  1969-12       Impact factor: 7.450

5.  Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France.

Authors:  N Breslow; C W Chan; G Dhom; R A Drury; L M Franks; B Gellei; Y S Lee; S Lundberg; B Sparke; N H Sternby; H Tulinius
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

6.  Increased risk of testicular germ cell cancer among infertile men.

Authors:  Thomas J Walsh; Mary S Croughan; Michael Schembri; June M Chan; Paul J Turek
Journal:  Arch Intern Med       Date:  2009-02-23

Review 7.  Prostate cancer epidemiology.

Authors:  Henrik Grönberg
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Microsatellite instability and defects in mismatch repair proteins: a new aetiology for Sertoli cell-only syndrome.

Authors:  M R Maduro; R Casella; E Kim; N Lévy; C Niederberger; L I Lipshultz; D J Lamb
Journal:  Mol Hum Reprod       Date:  2003-02       Impact factor: 4.025

10.  Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.

Authors:  N de Wind; M Dekker; A Berns; M Radman; H te Riele
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

View more
  42 in total

Review 1.  Is human fecundity changing? A discussion of research and data gaps precluding us from having an answer.

Authors:  Melissa M Smarr; Katherine J Sapra; Alison Gemmill; Linda G Kahn; Lauren A Wise; Courtney D Lynch; Pam Factor-Litvak; Sunni L Mumford; Niels E Skakkebaek; Rémy Slama; Danelle T Lobdell; Joseph B Stanford; Tina Kold Jensen; Elizabeth Heger Boyle; Michael L Eisenberg; Paul J Turek; Rajeshwari Sundaram; Marie E Thoma; Germaine M Buck Louis
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

Review 2.  Risk-based prostate cancer screening: who and how?

Authors:  Allison S Glass; K Clint Cary; Matthew R Cooperberg
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

3.  Risk of childhood mortality in family members of men with poor semen quality.

Authors:  Heidi A Hanson; Erik N Mayer; Ross E Anderson; Kenneth I Aston; Douglas T Carrell; Justin Berger; William T Lowrance; Ken R Smith; James M Hotaling
Journal:  Hum Reprod       Date:  2016-12-06       Impact factor: 6.918

Review 4.  Male reproductive health and prostate cancer risk.

Authors:  Thomas J Walsh
Journal:  Curr Opin Urol       Date:  2011-11       Impact factor: 2.309

5.  Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study.

Authors:  Michael L Eisenberg; Yikyung Park; Albert R Hollenbeck; Larry I Lipshultz; Arthur Schatzkin; Mark J Pletcher
Journal:  Hum Reprod       Date:  2011-09-26       Impact factor: 6.918

6.  Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.

Authors:  Ákos Végvári; Melinda Rezeli; Carina Sihlbom; Jari Häkkinen; Elisabet Carlsohn; Johan Malm; Hans Lilja; Thomas Laurell; György Marko-Varga
Journal:  Clin Biochem       Date:  2011-12-16       Impact factor: 3.281

Review 7.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

8.  Increased risk of cancer among azoospermic men.

Authors:  Michael L Eisenberg; Paul Betts; Danielle Herder; Dolores J Lamb; Larry I Lipshultz
Journal:  Fertil Steril       Date:  2013-06-21       Impact factor: 7.329

Review 9.  Urologic conditions associated with malignancy.

Authors:  Eric M Lo; James M Hotaling; Alexander W Pastuszak
Journal:  Urol Oncol       Date:  2019-01-02       Impact factor: 3.498

Review 10.  Oxidation-reduction potential of semen: what is its role in the treatment of male infertility?

Authors:  Ashok Agarwal; Shubhadeep Roychoudhury; Kimberly B Bjugstad; Chak-Lam Cho
Journal:  Ther Adv Urol       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.